aica ribonucleotide has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarhan, NI; Tahoon, NM; Zineldeen, DH | 1 |
| Krishnan U, A; Venkataraman, AC; Viswanathan, P | 1 |
2 other study(ies) available for aica ribonucleotide and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
AICAR Ameliorates Non-Alcoholic Fatty Liver Disease via Modulation of the HGF/NF-κB/SNARK Signaling Pathway and Restores Mitochondrial and Endoplasmic Reticular Impairments in High-Fat Diet-Fed Rats.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Lipid Metabolism; Liver; Male; Mitochondria; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Signal Transduction | 2023 |
AMPK activation by AICAR reduces diet induced fatty liver in C57BL/6 mice.
Topics: AMP-Activated Protein Kinases; Animals; Diet; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Rats; TOR Serine-Threonine Kinases | 2023 |